China Cutting Health-Care Costs Threatens Drugmaker Profits

China vowed to extend drug-price cuts, rankling some of the country’s largest manufacturers, in an overhaul of its health-care system to trim the cost of caring for an aging population.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.